Debra A Boelk

  • Citations Per Year
Learn More
PURPOSE The physical and chemical compatibility of drotrecogin alfa (activated) (recombinant human activated protein C) during simulated Y-site administration with drugs commonly used to treat patients with severe sepsis was determined. METHODS Thirty-four drugs were investigated for visual compatibility with drotrecogin alfa, and included cardiovascular(More)
  • 1